Literature DB >> 32043506

Homogeneous nucleation of Li2O2 under Li-O2 battery discharge.

Tatiana K Zakharchenko1, Artem V Sergeev, Alexander D Bashkirov, Polina Neklyudova, Antonio Cervellino, Daniil M Itkis, Lada V Yashina.   

Abstract

The development of high-energy lithium-oxygen batteries has significantly slowed by numerous challenges including capacity limitations due to electrode surface passivation by the discharge product Li2O2. Since the passivation rate and intensity are dependent on the deposit morphology, herein, we focus on the mechanisms governing Li2O2 formation within the porous cathode. We report evidence of homogeneous nucleation of Li2O2 crystallites and their further assembly in bulk of the electrolyte solution in DMSO, which possesses a high donor number. After careful estimation of the superoxide ion concentration distribution within a phenomenological model, it was found that the high stability of superoxide ions formed during the ORR towards disproportionation and sufficient diffusivity of (0.5-1.2) × 10-6 cm2 s-1 enabled Li2O2 nucleation and crystallization not only at the surface but also in the electrolyte, and the reaction zone spread throughout the internal space of the porous electrode. High initial supersaturation promoted the homogeneous nucleation of Li2O2 nanoplates, which instantly assembled into mesocrystals also in the solution bulk. These results were supported by operando SAXS/WAXS and morphology observations. Thus, although homogeneous nucleation is not dominant, it is important for achieving a high capacity in Li-O2 batteries.

Entities:  

Year:  2020        PMID: 32043506     DOI: 10.1039/c9nr08493b

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  1 in total

1.  Trapped interfacial redox introduces reversibility in the oxygen reduction reaction in a non-aqueous Ca2+ electrolyte.

Authors:  Yi-Ting Lu; Alex R Neale; Chi-Chang Hu; Laurence J Hardwick
Journal:  Chem Sci       Date:  2021-05-28       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.